Company intelligence / Profile preview

Claritas HealthTech

London, United Kingdom

Ownership: Private
Development stage: Other

Overview

Claritas HealthTech has developed image enhancement software and an AI-driven platform ('Providence AI') for clinicians to build, train, and deploy AI diagnostic tools tailored to specific clinical needs, and is in active commercial expansion with deployments expected in Asia, Europe, and North America in late 2024[2][3].

Modalities: DeviceSoftwareArtificial IntelligenceMachine Vision
Industry: Medical Imaging

Partnerships

Early deployment partners beyond current set, expanded rollout planned; no named major pharmaceutical/biotech partnerships disclosed[2].

Beyond the preview

Go deeper on Claritas HealthTech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Claritas HealthTech.

Explore the full profile